These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2. Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084 [TBL] [Abstract][Full Text] [Related]
5. Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of alpha(2A)-adrenoceptors. González-Maeso J; Rodríguez-Puertas R; Meana JJ; García-Sevilla JA; Guimón J Mol Psychiatry; 2002; 7(7):755-67. PubMed ID: 12192620 [TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor agonist-stimulated [35S]guanosine triphosphate gammaS binding in the brain of C57BL/6 and DBA/2 mice. Basavarajappa BS; Hungund BL J Neurosci Res; 2001 May; 64(4):429-36. PubMed ID: 11340650 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTP gamma S binding in synaptic plasma membrane from chronic ethanol exposed mouse. Basavarajappa BS; Hungund BL Brain Res; 1999 Jan; 815(1):89-97. PubMed ID: 9974126 [TBL] [Abstract][Full Text] [Related]
8. Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine. Rodríguez-Gaztelumendi A; Rojo ML; Pazos A; Díaz A J Neurochem; 2009 Mar; 108(6):1423-33. PubMed ID: 19183263 [TBL] [Abstract][Full Text] [Related]
9. Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects. Erdozain AM; Rubio M; Meana JJ; Fernández-Ruiz J; Callado LF J Psychopharmacol; 2015 Nov; 29(11):1137-45. PubMed ID: 26253623 [TBL] [Abstract][Full Text] [Related]
10. CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity. Baillie GL; Horswill JG; Anavi-Goffer S; Reggio PH; Bolognini D; Abood ME; McAllister S; Strange PG; Stephens GJ; Pertwee RG; Ross RA Mol Pharmacol; 2013 Feb; 83(2):322-38. PubMed ID: 23160940 [TBL] [Abstract][Full Text] [Related]
11. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain. Sim LJ; Childers SR J Comp Neurol; 1997 Oct; 386(4):562-72. PubMed ID: 9378852 [TBL] [Abstract][Full Text] [Related]
12. Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia. Andersson M; Terasmaa A; Fuxe K; Strömberg I J Neurosci Res; 2005 Oct; 82(2):264-72. PubMed ID: 16175569 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of CB₁ receptor binding in the ventromedial prefrontal cortex promotes proactive stress-coping strategies following chronic stress exposure. McLaughlin RJ; Hill MN; Dang SS; Wainwright SR; Galea LA; Hillard CJ; Gorzalka BB Behav Brain Res; 2013 Jan; 237():333-7. PubMed ID: 23047058 [TBL] [Abstract][Full Text] [Related]
14. Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats. Drew LJ; Harris J; Millns PJ; Kendall DA; Chapman V Eur J Neurosci; 2000 Jun; 12(6):2079-86. PubMed ID: 10886347 [TBL] [Abstract][Full Text] [Related]
15. Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes. Dennis I; Whalley BJ; Stephens GJ Br J Pharmacol; 2008 Jul; 154(6):1349-58. PubMed ID: 18493244 [TBL] [Abstract][Full Text] [Related]
16. Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas. De Jesús ML; Hostalot C; Garibi JM; Sallés J; Meana JJ; Callado LF Neurochem Int; 2010; 56(6-7):829-33. PubMed ID: 20307616 [TBL] [Abstract][Full Text] [Related]
17. PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats. Horswill JG; Bali U; Shaaban S; Keily JF; Jeevaratnam P; Babbs AJ; Reynet C; Wong Kai In P Br J Pharmacol; 2007 Nov; 152(5):805-14. PubMed ID: 17592509 [TBL] [Abstract][Full Text] [Related]
18. Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity. Hill MN; Barr AM; Ho WS; Carrier EJ; Gorzalka BB; Hillard CJ J Neurochem; 2007 Oct; 103(1):47-56. PubMed ID: 17561935 [TBL] [Abstract][Full Text] [Related]
19. The G protein-coupled cannabinoid-1 (CB1) receptor of mammalian brain: inhibition by phthalate esters in vitro. Bisset KM; Dhopeshwarkar AS; Liao C; Nicholson RA Neurochem Int; 2011 Oct; 59(5):706-13. PubMed ID: 21763743 [TBL] [Abstract][Full Text] [Related]
20. Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides. Vinod KY; Kassir SA; Hungund BL; Cooper TB; Mann JJ; Arango V J Psychiatr Res; 2010 Jul; 44(9):591-7. PubMed ID: 20015515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]